Answers are grounded in this paper and cite their sources.
We report a confirmed case of fetal and neonatal alloimmune thrombocytopenia (FNAIT) in a preterm Arab neonate born to a mother with a previously affected pregnancy. Antenatal management consisted of weekly intravenous immunoglobulin initiated at 16 weeks of gestation. Following delivery, the infant developed severe thrombocytopenia with a nadir platelet count of 25 × 10⁹/L but showed no evidence of intracranial hemorrhage. Treatment with two platelet transfusions followed by intravenous immunoglobulin resulted in a rapid recovery of platelet counts and an uncomplicated clinical course. This case highlights successful evidence-based antenatal and neonatal management of recurrent FNAIT in a Middle Eastern family and adds to the limited regional literature on immunogenetically confirmed cases.
No takes yet. Share an insight, caveat, or question.
Mohamad et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: